BioAge Labs Inc. (BIOA)
NASDAQ: BIOA
· Real-Time Price · USD
4.45
-0.01 (-0.22%)
At close: Aug 15, 2025, 12:12 PM
BioAge Labs Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | 3.86M | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.45M | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -91.33M | -81.83M | -78.19M | -66.43M | -51.56M | -49.71M | -48.4M | -34.8M | -24.92M | -11.51M |
Interest Income | 6.13M | 8.33M | 9.63M | 5.91M | 4.38M | 2.49M | 2.43M | 2.05M | 1.55M | 1.24M |
Pretax Income | -79.03M | -71.05M | -71.11M | -70.94M | -62.16M | -65.76M | -63.85M | -42.9M | -28.27M | -11.08M |
Net Income | -79.03M | -71.05M | -71.11M | -70.94M | -62.16M | -65.76M | -63.85M | -42.9M | -28.27M | -11.08M |
Selling & General & Admin | 25M | 22.45M | 19.16M | 16.54M | 15.16M | 14.54M | 14.51M | 11M | 7.64M | 3.47M |
Research & Development | 70.2M | 60.82M | 59.04M | 49.89M | 36.41M | 35.17M | 33.89M | 23.8M | 17.27M | 8.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 95.19M | 83.28M | 78.19M | 66.43M | 51.56M | 49.71M | 48.4M | 34.8M | 24.92M | 11.51M |
Interest Expense | 251K | 895K | 2.37M | 4.61M | 6.62M | 8.22M | 7.79M | 5.24M | 2.83M | 793K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.01M | 83.28M | 78.19M | 66.43M | 51.56M | 49.71M | 48.4M | 34.8M | 24.92M | 11.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 35.85M | 35.85M | 35.85M | 3.49M | 7.55M | 7.47M | 7.47M | 7.46M | 7.46M | 7.46M |
Shares Outstanding (Diluted) | 35.85M | 35.85M | 35.85M | 3.49M | 7.55M | 7.47M | 7.47M | 7.46M | 7.46M | 7.46M |
EPS (Basic) | -9.63 | -10.83 | -12.21 | -13.05 | -8.31 | -8.81 | -8.55 | -5.74 | -3.78 | -1.48 |
EPS (Diluted) | -9.63 | -10.83 | -12.21 | -13.05 | -8.31 | -8.81 | -8.55 | -5.74 | -3.78 | -1.48 |
EBITDA | -84.96M | -73.28M | -68.58M | -66.17M | -55.36M | -57.38M | -55.9M | -37.54M | -25.37M | -10.26M |
EBIT | -60.27M | -73.41M | -68.74M | -66.33M | -55.53M | -57.54M | -56.06M | -37.66M | -25.44M | -10.29M |
Depreciation & Amortization | 122K | 171K | 167K | 161K | 171K | 162K | 162K | 121K | 73K | 33K |